SPC486

Aprocitentan eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    4.12.2024
  • Application published:
    15.1.2025
  • Grant published:
    15.12.2025
  • Max expiry date:
    14.8.2033
  • Medicine name:
    Jeraygo
  • Medicine for children:
    No

Timeline

Today
4.12.2024Application
15.1.2025Publication
15.12.2025Registration
14.8.2033Expires

Marketing license

  • IS authorization number:
    EU/1/24/1818
  • Date:
    16.8.2024
  • Foreign authorization number:
    EU/1/24/1818
  • Date:
    27.6.2024

Owner

  • Name:
    Idorsia Pharmaceuticals Ltd
  • Address:
    Hegenheimermattweg 91, Allschwil CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents